GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants

Contributed by: Business Wire

Logo

Images

GC Aesthetics' PERLE™ Breast Implant features a proprietary surface technology (BioQ™) and GCA’s industry-leading gel technology (Emunomic™ Breast Tissue Dynamic Gel). (Photo: Business Wire)

Business Wire embedded0

Tags

Women

Surgery

Health

Medical Devices

Health Technology

Consumer

Clinical Trials

Other Health

More Like This

New Independent Clinical Study Showcases Safety and Efficacy of GC Aesthetics' PERLE Breast Implant

GC Aesthetics® Launches YOUTHLY™: A New Era for Breast Implants in China

GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally

GC Aesthetics® Strengthens Board of Directors with Strategic Appointments

IMCAS 2025: Galderma’s Broad Presence and New Data on Recently Launched Products Restylane® SHAYPE™ and Relfydess® Reaffirm Its Category Leadership

AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community

IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position

AMWC 2024: Galderma to Share New Data From Its Leading Injectable Aesthetic Portfolio